Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers

Gastroesophageal cancer is one of the most common cancers in the world, with a high rate of mortality. While there has been significant progress over the past decade, particularly with the addition of anti-HER2 therapies to platinum-based chemotherapy agents in the advanced setting, the prognosis re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Jeremy, Klempner, Samuel, Waters, Kevin, Atkins, Katelyn, Chao, Joseph, Cho, May, Hendifar, Andrew, Gangi, Alexandra, Burch, Miguel, Mehta, Pareen, Gong, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149813/
https://www.ncbi.nlm.nih.gov/pubmed/35645244
http://dx.doi.org/10.3390/diseases10020023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149813/
https://www.ncbi.nlm.nih.gov/pubmed/35645244
http://dx.doi.org/10.3390/diseases10020023

Ejemplares similares